FDA Approves Drug to Cut Cholesterol

Source: PharmaManufacturing.com

May 06, 2013

The New York Times

The Food and Drug Administration approved a combination drug developed by Merck that lowers a patient’s cholesterol but has not been shown to reduce the risk of cardiovascular disease or death, the company said.

The drug pairs Merck’s Zetia, which lowers low-density lipoprotein (LDL or “bad cholesterol”) with the generic version of Lipitor, the best-selling statin made by Pfizer that lost its patent protection in 2011. Read the full story.